Average Co-Inventor Count = 5.58
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (4 from 919 patents)
2. Celgene Corporation (3 from 549 patents)
3. Otsuka America Pharmaceutical, Inc. (3 from 19 patents)
4. Wyeth (2 from 1,309 patents)
5. Ambit Biosciences Corporation (2 from 39 patents)
6. Neurovance, Inc. (2 from 7 patents)
7. Astrazeneca Ab (1 from 1,500 patents)
8. Progenics Pharmaceuticals, Inc. (1 from 67 patents)
9. Progenics Pharmamceuticals, Inc. (1 from 1 patent)
17 patents:
1. 11773098 - Solid forms of a toll-like receptor modulator
2. 11299458 - Crystalline compounds
3. 10946004 - Solid forms of an ASK1 inhibitor
4. 10800740 - Crystalline compounds
5. 10508117 - Solid forms of a toll-like receptor modulator
6. 10280141 - Crystalline compounds
7. 9879024 - Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
8. 9856217 - Crystalline compounds
9. 9708261 - Crystalline compounds
10. 9643956 - Solid forms of an ASK1 inhibitor
11. 9624271 - Romidepsin solid forms and uses thereof
12. 9585892 - Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
13. 9518094 - Romidepsin solid forms and uses thereof
14. 9102680 - Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof
15. 8980825 - Romidepsin solid forms and uses thereof